SCHEMBL8772502

SCHEMBL8772502

COc1ccc([S+]([O-])C2CC(=O)N2CC(=O)CCc2ccccc2)cc1OC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.42
KMT2A Q03164 2/20 0.41
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41
POLB P06746 2/20 0.41
TP53 P04637 1/20 0.41
MAPK1 P28482 1/20 0.39
ALDH1A1 P00352 3/20 0.39
TSHR P16473 1/20 0.39
PDE4B Q07343 3/20 0.39
PDE4A P27815 2/20 0.39
PDE4C Q08493 2/20 0.39
PDE4D Q08499 2/20 0.39
PLAAT3 P53816 1/20 0.39
PLAAT5 Q96KN8 1/20 0.39
PLAAT2 Q9NWW9 1/20 0.39
PLAAT4 Q9UL19 1/20 0.39
CHRM5 P08912 1/20 0.38
CHRM1 P11229 1/20 0.38
CHRM3 P20309 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8772456 0.87 NPC1 (0.44) ALOX5NPC1RAB9APOLBTP53
SCHEMBL8772457 0.86 RAB9A (0.42) ALOX5KMT2ANPC1RAB9APOLB
SCHEMBL8772438 0.85 HCRTR1 (0.42) ALOX5POLBHCRTR1HCRTR2
SCHEMBL8442244 0.84 HMOX1 (0.40) NPC1POLBMAPK1ALDH1A1
SCHEMBL8772382 0.84 HMOX1 (0.40) NPC1POLBMAPK1ALDH1A1
SCHEMBL8443496 0.84 HMOX1 (0.40) NPC1POLBMAPK1ALDH1A1
SCHEMBL8443497 0.84 HMOX1 (0.40) NPC1POLBMAPK1ALDH1A1
SCHEMBL8772555 0.83 TP53 (0.43) KMT2ANPC1RAB9APOLBTP53
SCHEMBL8772514 0.80 HCRTR1 (0.41) ALOX5KMT2APOLBHCRTR1HCRTR2
SCHEMBL8102560 0.79 HMOX1 (0.40) ALOX5NPC1POLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996019451-A1 SUBSTITUTED AZETIDIN-2-ONES FOR TREATMENT OF ATHEROSCLEROSIS SMITHKLINE BEECHAM PLC (GB) 1996-06-27 WO claimed
EP-0799200-A1 SUBSTITUTED AZETIDIN-2-ONES FOR TREATMENT OF ATHEROSCLEROSIS SMITHKLINE BEECHAM PLC (GB) 1997-10-08 EP disclosed
WO-1996019451-A1 SUBSTITUTED AZETIDIN-2-ONES FOR TREATMENT OF ATHEROSCLEROSIS SMITHKLINE BEECHAM PLC (GB) 1996-06-27 WO disclosed